IBT
KRTX

International Biotechnology Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

International Biotechnology Trust’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$5.16M Buy
30,500
+4,800
+19% +$903K 1.74% 21
2023
Q2 		$5.57M Buy
25,700
+14,700
+134% +$3.15M 1.69% 19
2023
Q1 		$2M Buy
+11,000
New +$2.1M 0.56% 39
2022
Q3 		– Sell
-1,567
Closed -$12.4K – 82
2022
Q2 		$12.4K Buy
+1,567
New +$180K 0.13% 73

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

International Biotechnology Trust's KRTX Position: Q3 2023 in Review

International Biotechnology Trust increased its Karuna Therapeutics, Inc. Common Stock (KRTX) stake by 19% in Q3 2023, buying an estimated $903K and bringing the position to 30,500 shares worth $5.16M. The position accounts for 1.74% of the portfolio, ranked #21.

International Biotechnology Trust first reported a position in KRTX in Q2 2022 and has held it in 4 quarters since. The position peaked at $5.57M in Q2 2023. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

  • International Biotechnology Trust held 30,500 shares of Karuna Therapeutics, Inc. Common Stock worth $5.16M as of Q3 2023.
  • International Biotechnology Trust bought 4,800 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $903K.
  • Karuna Therapeutics, Inc. Common Stock made up 1.74% of International Biotechnology Trust's portfolio in Q3 2023, its #21 holding.
  • International Biotechnology Trust first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and has held it in 4 quarters since.
  • International Biotechnology Trust's Karuna Therapeutics, Inc. Common Stock position peaked at $5.57M in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.